COVID-19 trials: declarations of data sharing intentions at trial registration and at publication
Abstract Background The sharing of individual participant-level data from COVID-19 trials would allow re-use and secondary analysis that can help accelerate the identification of effective treatments. The sharing of trial data is not the norm, but the unprecedented pandemic caused by SARS-CoV-2 may...
Main Authors: | Rebecca Li, Megan von Isenburg, Marcia Levenstein, Stan Neumann, Julie Wood, Ida Sim |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-02-01
|
Series: | Trials |
Online Access: | https://doi.org/10.1186/s13063-021-05104-z |
Similar Items
-
Beyond trial registration: a global trial bank for clinical trial reporting.
by: Ida Sim, et al.
Published: (2005-11-01) -
Trial registration numbers are underreported in biomedical publications.
by: Fleur T van de Wetering, et al.
Published: (2012-01-01) -
Registration of clinical trials
by: Reza Negarandeh*, et al.
Published: (2018-07-01) -
Clinical trials registration.
by: Frank W Rockhold, et al.
Published: (2006-03-01) -
Trial publication after registration in ClinicalTrials.Gov: a cross-sectional analysis.
by: Joseph S Ross, et al.
Published: (2009-09-01)